TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

CUSIP: 874060205

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / SPONSORED ADS
Total 13F shares
80,437,115
Share change
-4,233,270
Total reported value
$1,242,500,598
Put/Call ratio
18%
Price per share
$15.47
Number of holders
310
Value change
-$66,352,882
Number of buys
142
Number of sells
120

Quarterly Holders Quick Answers

What is CUSIP 874060205?
CUSIP 874060205 identifies TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2023

As of 30 Sep 2023, TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by 310 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,437,115 shares. The largest 10 holders included Capital Research Global Investors, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Mondrian Investment Partners LTD, MILLENNIUM MANAGEMENT LLC, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and BlackRock Inc.. This page lists 310 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.